Pneumocystis Colonization Is Associated with Enhanced Pulmonary Remodeling and Activation of Redox-Responsive

Andrea Méndez1,2, Krishna Coronado3, Diego A Rojas3

  • 1Escuela de Kinesiología, Facultad de Salud y CIencias Sociales, Campus Providencia, Sede Santiago, Universidad de Las Américas, Santiago 7500975, Chile.

Insights

Pneumocystis fungal colonization worsens Chronic Obstructive Pulmonary Disease (COPD) lung damage and inflammation. This fungal co-infection amplifies airway remodeling and activates antioxidant pathways in experimental COPD models.

Area of Science:

  • Pulmonary Medicine
  • Medical Mycology
  • Molecular Biology

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) involves lung inflammation and structural changes, often linked to oxidative stress.
  • Pneumocystis fungal colonization is observed in COPD patients and associated with poorer outcomes, but its role in airway remodeling is not fully understood.

Purpose of the Study:

  • To investigate the impact of Pneumocystis colonization on airway remodeling and oxidative stress in an experimental COPD model.
  • To elucidate the molecular mechanisms underlying the interaction between Pneumocystis and COPD lung pathology.

Main Methods:

  • An elastase-induced COPD model in rodents was established and subsequently colonized with Pneumocystis.
  • Lung tissues were analyzed using histological and molecular techniques to assess inflammation, epithelial changes, alveolar damage, and oxidative stress markers.
  • Expression levels of antioxidant pathway markers, including Nrf2 and Hmox1, were quantified.

Main Results:

  • Pneumocystis co-exposure significantly exacerbated emphysematous damage, airway inflammation, epithelial thickness, and collagen deposition compared to COPD or Pneumocystis alone.
  • Antioxidant markers like SOD and catalase were upregulated, alongside increased Nrf2 and Hmox1 expression, particularly in co-exposed animals.
  • Pneumocystis burden positively correlated with lung damage, inflammation, and remodeling, indicating its role as an amplifying factor.

Conclusions:

  • Pneumocystis colonization exacerbates pulmonary remodeling and modulates antioxidant signaling in experimental COPD.
  • These structural and molecular changes driven by Pneumocystis may contribute to COPD progression.
  • Pneumocystis acts as an amplifying factor in COPD-associated lung damage, highlighting potential therapeutic targets.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: